drug · small molecule
patient view →ibrexafungerp citrate
Marketedupdated 2mo agoby $GSK GSK plc🔗 ChEMBL
Approvedcommunity read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for vulvovaginal candidiasis and 1 investigational indication.
targets
1,3-beta-glucan synthase
all catalysts(4)
approval · 4
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that